Trial intelligence / Profile preview

Long-term retrospective study of Five-Flavor Sophora Flavescens enteric-coated capsules in ulcerative colitis

ChiCTR2400088375Phase 4Recruiting

Sponsor
Peking Union Medical College Hospital
Start
Jan 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of Wuwei Kushen in autoimmune colitis, sponsored by Peking Union Medical College Hospital. Primary endpoints: Change in fecal bleeding score, Blood routine parameters and 7 more. Started Jan 2024; status: recruiting.

02

Drugs

Wuwei Kushen
03

Conditions

autoimmune colitis

Beyond the preview

Go deeper on ChiCTR2400088375.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400088375.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call